Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 11199 | 28.33 |
09:34 ET | 3066 | 28.27 |
09:36 ET | 1508 | 28.27 |
09:38 ET | 1200 | 28.2 |
09:39 ET | 2168 | 28.2157 |
09:41 ET | 1124 | 28.225 |
09:43 ET | 5222 | 28.26 |
09:45 ET | 3960 | 28.28 |
09:48 ET | 7947 | 28.205 |
09:50 ET | 3970 | 28.26 |
09:52 ET | 10674 | 28.265 |
09:54 ET | 2887 | 28.265 |
09:56 ET | 1927 | 28.28 |
09:57 ET | 1400 | 28.295 |
09:59 ET | 2349 | 28.3 |
10:01 ET | 5075 | 28.34 |
10:03 ET | 1551 | 28.37 |
10:06 ET | 896 | 28.34 |
10:08 ET | 1461 | 28.315 |
10:10 ET | 1500 | 28.295 |
10:12 ET | 3051 | 28.27 |
10:14 ET | 11034 | 28.29 |
10:15 ET | 2591 | 28.285 |
10:17 ET | 3186 | 28.29 |
10:19 ET | 3565 | 28.235 |
10:21 ET | 10260 | 28.265 |
10:24 ET | 601 | 28.305 |
10:26 ET | 973 | 28.31 |
10:28 ET | 3399 | 28.295 |
10:30 ET | 4638 | 28.295 |
10:32 ET | 1014 | 28.315 |
10:33 ET | 1634 | 28.315 |
10:35 ET | 9172 | 28.375 |
10:37 ET | 2685 | 28.409 |
10:39 ET | 3925 | 28.43 |
10:42 ET | 1461 | 28.425 |
10:44 ET | 1793 | 28.41 |
10:46 ET | 2085 | 28.39 |
10:48 ET | 3327 | 28.38 |
10:50 ET | 3150 | 28.355 |
10:51 ET | 444 | 28.355 |
10:53 ET | 5926 | 28.365 |
10:55 ET | 1943 | 28.37 |
10:57 ET | 1148 | 28.37 |
11:00 ET | 915 | 28.375 |
11:02 ET | 1817 | 28.385 |
11:04 ET | 897 | 28.385 |
11:06 ET | 615 | 28.395 |
11:08 ET | 6225 | 28.385 |
11:09 ET | 812 | 28.385 |
11:11 ET | 2591 | 28.375 |
11:13 ET | 1384 | 28.38 |
11:15 ET | 12578 | 28.3709 |
11:18 ET | 13514 | 28.395 |
11:20 ET | 2116 | 28.405 |
11:22 ET | 4390 | 28.385 |
11:24 ET | 3502 | 28.38 |
11:26 ET | 1078 | 28.385 |
11:27 ET | 7074 | 28.385 |
11:29 ET | 32831 | 28.5269 |
11:31 ET | 7253 | 28.515 |
11:33 ET | 664 | 28.5103 |
11:36 ET | 2001 | 28.54 |
11:38 ET | 7293 | 28.48 |
11:40 ET | 9174 | 28.455 |
11:42 ET | 5859 | 28.475 |
11:44 ET | 8127 | 28.495 |
11:45 ET | 2080 | 28.485 |
11:47 ET | 5014 | 28.495 |
11:49 ET | 4454 | 28.465 |
11:51 ET | 2968 | 28.495 |
11:54 ET | 2943 | 28.485 |
11:56 ET | 2776 | 28.495 |
11:58 ET | 1831 | 28.4901 |
12:00 ET | 18730 | 28.505 |
12:02 ET | 3278 | 28.495 |
12:03 ET | 3849 | 28.525 |
12:05 ET | 2268 | 28.535 |
12:07 ET | 476 | 28.545 |
12:09 ET | 4745 | 28.535 |
12:12 ET | 4922 | 28.505 |
12:14 ET | 6847 | 28.48 |
12:16 ET | 3234 | 28.445 |
12:18 ET | 4110 | 28.44 |
12:20 ET | 2873 | 28.42 |
12:21 ET | 1520 | 28.435 |
12:23 ET | 1280 | 28.43 |
12:25 ET | 1508 | 28.4 |
12:27 ET | 3984 | 28.39 |
12:30 ET | 2102 | 28.385 |
12:32 ET | 3150 | 28.385 |
12:34 ET | 3497 | 28.37 |
12:36 ET | 1468 | 28.365 |
12:38 ET | 1508 | 28.365 |
12:39 ET | 489 | 28.355 |
12:41 ET | 3394 | 28.345 |
12:43 ET | 1743 | 28.325 |
12:45 ET | 1202 | 28.325 |
12:48 ET | 1295 | 28.315 |
12:50 ET | 5221 | 28.305 |
12:52 ET | 7911 | 28.315 |
12:54 ET | 1542 | 28.335 |
12:56 ET | 2113 | 28.3575 |
12:57 ET | 3407 | 28.34 |
12:59 ET | 2204 | 28.34 |
01:01 ET | 2660 | 28.33 |
01:03 ET | 3555 | 28.345 |
01:06 ET | 2531 | 28.335 |
01:08 ET | 2500 | 28.3 |
01:10 ET | 2558 | 28.305 |
01:12 ET | 4432 | 28.285 |
01:14 ET | 369 | 28.285 |
01:15 ET | 1314 | 28.285 |
01:17 ET | 7827 | 28.22 |
01:19 ET | 3403 | 28.235 |
01:21 ET | 1595 | 28.235 |
01:24 ET | 2518 | 28.225 |
01:26 ET | 6045 | 28.205 |
01:28 ET | 2002 | 28.2 |
01:30 ET | 1231 | 28.205 |
01:32 ET | 826 | 28.195 |
01:33 ET | 8209 | 28.205 |
01:35 ET | 2314 | 28.225 |
01:37 ET | 1415 | 28.2 |
01:39 ET | 1667 | 28.195 |
01:42 ET | 1795 | 28.2 |
01:44 ET | 2110 | 28.215 |
01:46 ET | 1576 | 28.215 |
01:48 ET | 1690 | 28.235 |
01:50 ET | 462 | 28.235 |
01:51 ET | 3543 | 28.235 |
01:53 ET | 4507 | 28.225 |
01:55 ET | 468 | 28.23 |
01:57 ET | 3883 | 28.25 |
02:00 ET | 2186 | 28.235 |
02:02 ET | 2136 | 28.225 |
02:04 ET | 713 | 28.235 |
02:06 ET | 442 | 28.235 |
02:08 ET | 3182 | 28.24 |
02:09 ET | 300 | 28.245 |
02:11 ET | 1584 | 28.235 |
02:13 ET | 276 | 28.235 |
02:15 ET | 1633 | 28.215 |
02:18 ET | 3532 | 28.215 |
02:20 ET | 740 | 28.215 |
02:22 ET | 1627 | 28.215 |
02:24 ET | 247 | 28.215 |
02:26 ET | 4033 | 28.21 |
02:27 ET | 2220 | 28.215 |
02:29 ET | 453 | 28.216 |
02:31 ET | 2598 | 28.225 |
02:33 ET | 5688 | 28.27 |
02:36 ET | 3611 | 28.265 |
02:38 ET | 1666 | 28.245 |
02:40 ET | 736 | 28.26 |
02:42 ET | 574 | 28.255 |
02:44 ET | 3993 | 28.245 |
02:45 ET | 2907 | 28.255 |
02:47 ET | 1114 | 28.255 |
02:49 ET | 3775 | 28.27 |
02:51 ET | 2977 | 28.27 |
02:54 ET | 3231 | 28.255 |
02:56 ET | 3141 | 28.275 |
02:58 ET | 2674 | 28.275 |
03:00 ET | 1746 | 28.275 |
03:02 ET | 17333 | 28.3 |
03:03 ET | 4003 | 28.295 |
03:05 ET | 1071 | 28.295 |
03:07 ET | 1019 | 28.295 |
03:09 ET | 2479 | 28.315 |
03:12 ET | 1300 | 28.305 |
03:14 ET | 1121 | 28.305 |
03:16 ET | 4232 | 28.295 |
03:18 ET | 3441 | 28.295 |
03:20 ET | 4152 | 28.285 |
03:21 ET | 4099 | 28.285 |
03:23 ET | 2265 | 28.305 |
03:25 ET | 1987 | 28.315 |
03:27 ET | 2479 | 28.3 |
03:30 ET | 5989 | 28.305 |
03:32 ET | 8578 | 28.305 |
03:34 ET | 6669 | 28.285 |
03:36 ET | 5998 | 28.305 |
03:38 ET | 21593 | 28.295 |
03:39 ET | 42981 | 28.325 |
03:41 ET | 4092 | 28.355 |
03:43 ET | 5737 | 28.3609 |
03:45 ET | 2927 | 28.35 |
03:48 ET | 4640 | 28.34 |
03:50 ET | 5936 | 28.335 |
03:52 ET | 14270 | 28.3 |
03:54 ET | 14064 | 28.325 |
03:56 ET | 22143 | 28.355 |
03:57 ET | 24203 | 28.38 |
03:59 ET | 434726 | 28.38 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.8B | 18.9x | +1.83% |
Amneal Pharmaceuticals Inc | 2.6B | -14.0x | --- |
Endo Inc | 1.9B | 0.4x | --- |
Catalent Inc | 11.0B | -10.5x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 18.7x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 593.5M |
Dividend Yield | 2.96% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.9x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 20.0x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.